Billiontoone (NASDAQ:BLLN) Trading Up 6.2% - What's Next?

Key Points

• BillionToOne shares rose 6.2% to about $110.33, although trading volume was 57% below the average session. The stock’s market capitalization is approximately $5.38 billion, with a P/E ratio of 162.55.
• Analyst sentiment is mixed: seven analysts rate the stock Buy, two rate it Hold and two rate it Sell. The consensus rating is Hold, with an average price target of $125.88.
• The company met quarterly EPS estimates at $0.15 and reported $109.45 million in revenue, but insiders have sold 248,160 shares worth approximately $28.4 million over the past 90 days, including substantial sales by the CEO and a senior vice president.

Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report)'s share price rose 6.2% on Tuesday . The company traded as high as $111.50 and last traded at $110.3260. Approximately 235,175 shares traded hands during trading, a decline of 57% from the average session volume of 545,141 shares. The stock had previously closed at $103.86.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on BLLN. Zacks Research lowered Billiontoone from a "hold" rating to a "strong sell" rating in a research note on Monday, August 31st. Canaccord Genuity Group initiated coverage on shares of Billiontoone in a research report on Wednesday, September 2nd. They issued a "buy" rating and a $120.00 price objective for the company. Weiss Ratings reiterated a "sell (d+)" rating on shares of Billiontoone in a research note on Friday. BTIG Research decreased their target price on shares of Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a research note on Thursday, August 6th. Finally, Wall Street Zen lowered shares of Billiontoone from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Seven analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Billiontoone has an average rating of "Hold" and a consensus price target of $125.88.

Billiontoone Trading Up 9.7%

The business has a 50 day simple moving average of $109.42 and a two-hundred day simple moving average of $97.24. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. The stock has a market cap of $5.38 billion and a price-to-earnings ratio of 162.55.

Billiontoone (NASDAQ:BLLN - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.15. The company had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. As a group, equities analysts anticipate that Billiontoone, Inc. will post 0.83 EPS for the current year.

Insider Activity at Billiontoone

In other Billiontoone news, SVP Bosch John Roderick Ten sold 1,416 shares of the firm's stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64. Following the completion of the transaction, the senior vice president directly owned 25,051 shares of the company's stock, valued at $2,443,474.54. This trade represents a 5.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 24,999 shares of the business's stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $100.32, for a total transaction of $2,507,899.68. Following the completion of the sale, the chief executive officer directly owned 16,666 shares of the company's stock, valued at $1,671,933.12. The trade was a 60.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 248,160 shares of company stock worth $28,404,042 in the last ninety days. 50.22% of the stock is currently owned by corporate insiders.

Institutional Trading of Billiontoone

Institutional investors have recently added to or reduced their stakes in the business. Integrated Wealth Concepts LLC bought a new position in Billiontoone in the 2nd quarter valued at about $29,000. MCF Advisors LLC lifted its position in shares of Billiontoone by 330.8% during the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock valued at $54,000 after acquiring an additional 344 shares during the last quarter. Thrive Wealth Management LLC bought a new stake in shares of Billiontoone during the 2nd quarter worth $240,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Billiontoone in the 4th quarter worth $230,000. Finally, Jasper Ridge Partners L.P. acquired a new stake in shares of Billiontoone during the second quarter worth $615,000.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company's technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company's primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.